CytoDyn (CYDY) Cash from Operations (2010 - 2026)
CytoDyn (CYDY) posted Cash from Operations of 5519000.0 for Q1 2026, down 26.87% on a QoQ basis from 4350000.0 in Q4 2025, and down 11.36% year-over-year from 6226306.4 in Q1 2025.
CytoDyn (CYDY) Cash from Operations (2010 - 2026) Analysis & Trends
CytoDyn's Cash from Operations history runs 17 years deep, the most recent figure standing at 5519000.0 for Q1 2026.
- Quarterly Cash from Operations fell 11.36% year-over-year to 5519000.0 in Q1 2026, while the trailing twelve-month figure through Feb 2026 was 17982000.0 (down 278.41% YoY) and the FY2025 annual result came in at 8765000.0, up 20.19% from the prior year.
- Cash from Operations was 5519000.0 for Q1 2026 at CytoDyn, down from 4350000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 5440000.0 in Q3 2024 and bottomed at 11074000.0 in Q3 2022.
- A 5-year average of 4368647.06 and a median of 4406000.0 in 2022 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2024 — Cash from Operations jumped 221.02% — and 2025, when it plunged 243.21%.
- CytoDyn's Cash from Operations stood at 4406000.0 in 2022, then soared by 43.21% to 2502000.0 in 2023, then tumbled by 43.33% to 3586000.0 in 2024, then declined by 21.31% to 4350000.0 in 2025, then decreased by 26.87% to 5519000.0 in 2026.
- Business Quant data shows CYDY's Cash from Operations at 5519000.0 in Q1 2026, 4350000.0 in Q4 2025, and 2450000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | CytoDyn | 267.79 Mn | 267.79 Mn | - | -5.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -5.52 Mn |
| Feb 28, 2026 | -5.52 Mn |
| Nov 30, 2025 | -4.35 Mn |
| Nov 30, 2025 | -4.35 Mn |
| Aug 31, 2025 | -2.45 Mn |
| Aug 31, 2025 | -2.45 Mn |
| May 31, 2025 | -5.66 Mn |
| May 31, 2025 | -5.66 Mn |
| Feb 28, 2025 | -4.96 Mn |
| Feb 28, 2025 | -4.96 Mn |
| Nov 30, 2024 | -3.59 Mn |
| Nov 30, 2024 | -3.59 Mn |
| Aug 31, 2024 | 5.44 Mn |
| Aug 31, 2024 | 5.44 Mn |
| May 31, 2024 | -1.65 Mn |
| May 31, 2024 | -1.65 Mn |
| Feb 29, 2024 | -2.34 Mn |
| Feb 29, 2024 | -2.34 Mn |
| Nov 30, 2023 | -2.50 Mn |
| Nov 30, 2023 | -2.50 Mn |